Tingxi Guo

1.7k total citations · 2 hit papers
22 papers, 1.3k citations indexed

About

Tingxi Guo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Tingxi Guo has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 16 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Tingxi Guo's work include Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (16 papers) and T-cell and B-cell Immunology (10 papers). Tingxi Guo is often cited by papers focused on Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (16 papers) and T-cell and B-cell Immunology (10 papers). Tingxi Guo collaborates with scholars based in Canada, Japan and United States. Tingxi Guo's co-authors include Naoto Hirano, Marcus O. Butler, Kayoko Saso, Yuki Kagoya, Mark Anczurowski, Chung-Hsi Wang, Shinya Tanaka, Mark D. Minden, Munehide Nakatsugawa and Timothy K. Lu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Tingxi Guo

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects

2018 446 citations Yuki Kagoya, Shinya Tanaka et al. Nature Medicine profile →
Engineering living therapeutics with synthetic biology

2021 207 citations Andrés Cubillos-Ruiz, Tingxi Guo et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tingxi Guo Canada	14	834	531	511	296	252	22	1.3k
Valentin Voillet United States	14	847 1.0×	522 1.0×	446 0.9×	297 1.0×	228 0.9×	26	1.3k
Ming-Ru Wu United States	12	423 0.5×	359 0.7×	349 0.7×	142 0.5×	121 0.5×	18	837
Agnès Gouble France	16	635 0.8×	160 0.3×	904 1.8×	175 0.6×	456 1.8×	37	1.3k
Kurt Schönfeld Germany	11	1.1k 1.4×	969 1.8×	369 0.7×	249 0.8×	267 1.1×	19	1.6k
Fernando Pastor Spain	23	565 0.7×	784 1.5×	1.4k 2.7×	252 0.9×	96 0.4×	49	2.1k
Shirley Bartido United States	11	416 0.5×	323 0.6×	295 0.6×	109 0.4×	246 1.0×	24	766
Sachiko Okamoto Japan	15	644 0.8×	482 0.9×	578 1.1×	95 0.3×	285 1.1×	37	1.2k
Jessica Wenthe Sweden	11	611 0.7×	315 0.6×	225 0.4×	108 0.4×	312 1.2×	24	799
Hiroki Torikai United States	17	957 1.1×	634 1.2×	577 1.1×	235 0.8×	452 1.8×	32	1.4k
Ashlesha Odak United States	4	1.1k 1.3×	353 0.7×	775 1.5×	328 1.1×	469 1.9×	5	1.3k

Countries citing papers authored by Tingxi Guo

Since Specialization

Citations

This map shows the geographic impact of Tingxi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingxi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingxi Guo more than expected).

Fields of papers citing papers by Tingxi Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingxi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingxi Guo. The network helps show where Tingxi Guo may publish in the future.

Co-authorship network of co-authors of Tingxi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Tingxi Guo. A scholar is included among the top collaborators of Tingxi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingxi Guo. Tingxi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paul, Michael St., Samuel D. Saibil, SeongJun Han, et al.. (2024). Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy. Cell Reports Medicine. 5(3). 101465–101465. 9 indexed citations

Cubillos-Ruiz, Andrés, Tingxi Guo, Anna Sokolovska, et al.. (2021). Engineering living therapeutics with synthetic biology. Nature Reviews Drug Discovery. 20(12). 941–960. 207 indexed citations breakdown →

Sugata, Kenji, Yukiko Matsunaga, Yūki Yamashita, et al.. (2021). Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells. Nature Biotechnology. 39(8). 958–967. 14 indexed citations

Kagoya, Yuki, Tingxi Guo, Brian Yeung, et al.. (2020). Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy. Cancer Immunology Research. 8(7). 926–936. 126 indexed citations

Anczurowski, Mark, Kenji Sugata, Yukiko Matsunaga, et al.. (2019). Chaperones of the class I peptide-loading complex facilitate the constitutive presentation of endogenous antigens on HLA-DP84GGPM87. Journal of Autoimmunity. 102. 114–125. 2 indexed citations

Kagoya, Yuki, Hiroshi Saijo, Yukiko Matsunaga, et al.. (2018). Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells. Journal of Autoimmunity. 97. 10–21. 38 indexed citations

Kagoya, Yuki, Munehide Nakatsugawa, Kayoko Saso, et al.. (2018). DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models. Nature Communications. 9(1). 1915–1915. 22 indexed citations

Kagoya, Yuki, Shinya Tanaka, Tingxi Guo, et al.. (2018). A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects. Nature Medicine. 24(3). 352–359. 446 indexed citations breakdown →

Anczurowski, Mark, Yūki Yamashita, Munehide Nakatsugawa, et al.. (2018). Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly. Scientific Reports. 8(1). 4804–4804. 7 indexed citations

10.

Kagoya, Yuki, Munehide Nakatsugawa, Toshiki Ochi, et al.. (2017). Transient stimulation expands superior antitumor T cells for adoptive therapy. JCI Insight. 2(2). e89580–e89580. 44 indexed citations

11.

Yamashita, Yūki, Mark Anczurowski, Munehide Nakatsugawa, et al.. (2017). HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nature Communications. 8(1). 15244–15244. 29 indexed citations

12.

Kagoya, Yuki, Munehide Nakatsugawa, Yūki Yamashita, et al.. (2016). BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. Journal of Clinical Investigation. 126(9). 3479–3494. 168 indexed citations

13.

Guo, Tingxi, Kenji Chamoto, Munehide Nakatsugawa, et al.. (2016). Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors. PLoS ONE. 11(5). e0156114–e0156114. 4 indexed citations

14.

Nakatsugawa, Munehide, Yūki Yamashita, Toshiki Ochi, et al.. (2016). CD4+ and CD8+ TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells. Scientific Reports. 6(1). 23821–23821. 12 indexed citations

15.

Guo, Tingxi, Toshiki Ochi, Munehide Nakatsugawa, et al.. (2016). Generating <em>De Novo</em> Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain. Journal of Visualized Experiments. 2 indexed citations

16.

Chamoto, Kenji, Tingxi Guo, S.W. Scally, et al.. (2016). Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs. The Journal of Immunology. 198(3). 1056–1065. 3 indexed citations

17.

Ochi, Toshiki, Munehide Nakatsugawa, Kenji Chamoto, et al.. (2015). Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy. Cancer Immunology Research. 3(9). 1070–1081. 29 indexed citations

18.

Nakatsugawa, Munehide, Yūki Yamashita, Toshiki Ochi, et al.. (2015). Specific Roles of Each TCR Hemichain in Generating Functional Chain-Centric TCR. The Journal of Immunology. 194(7). 3487–3500. 37 indexed citations

19.

Guo, Tingxi, Kenji Chamoto, & Naoto Hirano. (2015). Adoptive T Cell Therapy Targeting CD1 and MR1. Frontiers in Immunology. 6. 247–247. 15 indexed citations

20.

Chamoto, Kenji, Tingxi Guo, Osamu Imataki, et al.. (2015). CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors. Journal of Autoimmunity. 68. 39–51. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact